| Batch Notification Number |
BN-OL-2022-10-27-5659
|
| FDA Registered Product/Generic Name |
Co-amoxiclav
|
| Brand Name |
CLAVSEF
|
| Dosage Strength |
400 mg/ 57 mg per 5 mL
|
| Dosage Form |
Powder for Oral Suspension
|
| Registration Number |
DRP-7086-08
|
| Batch Number |
N/A
|
| Lot Number |
2I251A2
|
| Product Expiration Date |
Mar 2024
|
| Issuance Date |
28 October 2022
|